Company / Revenue per Share
Aurinia Pharmaceuticals Inc. Revenue per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$2.01
FY2025
5-year range
$0.00 / $2.01
FY2021-FY2025
Trend
+22.9%
vs FY2024
Sector context
#88 of 154
Health Care
What the data says
At $2.01, Aurinia Pharmaceuticals Inc.'s revenue per share ranks #88 of 154 in the Health Care sector. Revenue per Share has increased for 4 consecutive years, from $0.00 in FY2021 to $2.01 in FY2025.
Based on SEC 10-K filings.
2.01 in FY2025 with a 5-year CAGR of +27.9%.
Improved from $1.24 to $2.01 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +71.9%
- 5-Year CAGR
- +27.9%
- 10-Year CAGR
- -
Sector benchmark
#88 of 154 in Health CareTop 57% of 154This company $2.01 Sector average $10.35
▼
-80.6% below sector average
Key checks
Key Insights
- Aurinia Pharmaceuticals Inc.'s revenue per share has grown for 4 consecutive years.
- In FY2025, revenue per share increased 22.9% year-over-year.
- Ranks #88 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.01 | +22.9% |
| FY2024 | $1.63 | +31.9% |
| FY2023 | $1.24 | +213.3% |
| FY2022 | $0.40 | +13806.9% |
| FY2021 | $0.00 | -99.5% |
| FY2020 | $0.59 | +17047.3% |
| FY2019 | $0.00 | -37.4% |
| FY2018 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026